Our Private Equity Group is considered the go-to practice for complex, bespoke and firm-defining transactions. With clients ranging from the world’s leading institutional asset managers to prominent middle-market private equity and growth equity firms, we offer comprehensive advice to general partners, limited partners, co-investors and other equity stakeholders, as well as portfolio companies, lenders and financial sponsor groups. The depth and continuity of our relationships across the industry gives us a nuanced understanding of each client’s objectives and allows us to provide seamless, efficient counsel across the investment lifecycle.
Atlas Neon Completes Tender Offer to Buy Out NGM Bio
- Client News
- April 5, 2024
Paul, Weiss advised The Column Group, LP (TCG) affiliate Atlas Neon Parent, Inc., in its cash tender offer to buy out NGM Biopharmaceuticals, Inc., a biotechnology company focused on discovering and developing transformative therapeutics for patients. An Atlas Neon merger subsidiary merged with and into NGM Bio, and NGM Bio became a privately held, wholly owned subsidiary of Atlas Neon Parent.
The Paul, Weiss team was led by corporate partners Austin Pollet and Luke Jennings, and included executive compensation partner Andrea Wahlquist Brown and counsel Sasha Belinkie and Christopher Gonnella; tax partner Matthew Jordan; intellectual property partner Jonathan Ashtor; litigation partner Andrew Gordon and counsel Steven Herzog; and antitrust counsel John Magruder and Chad de Souza.